Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Dec;44(12):3322-7.
doi: 10.1128/AAC.44.12.3322-3327.2000.

Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa

Affiliations

Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa

N Masuda et al. Antimicrob Agents Chemother. 2000 Dec.

Abstract

To find the exact substrate specificities of three species of tripartite efflux systems of Pseudomonas aeruginosa, MexAB-OprM, MexCD-OprJ, and MexXY-OprM, we constructed a series of isogenic mutants, each of which constitutively overproduced one of the three efflux systems and lacked the other two, and their isogenic mutants, which lacked all these systems. Comparison of the susceptibilities of the constructed mutants to 52 antimicrobial agents belonging to various groups suggested the following substrate specificities. All of the efflux systems extrude a wide variety of antimicrobial agent groups, i.e., quinolones, macrolides, tetracyclines, lincomycin, chloramphenicol, most penicillins (all but carbenicillin and sulbenicillin), most cephems (all but cefsulodin and ceftazidime), meropenem, and S-4661, but none of them extrude polymyxin B or imipenem. Extrusion of aminoglycosides is specific to MexXY-OprM, and extrusion of a group of the beta-lactams, i.e., carbenicillin, sulbenicillin, ceftazidime, moxalactam, and aztreonam, is specific to MexAB-OprM. Moreover, MexAB-OprM and MexCD-OprJ extrude novobiocin, cefsulodin, and flomoxef, while MexXY-OprM does not. These substrate specificities are distinct from those reported previously.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Detection of MexA, MexC, and MexX with antisera directed against synthetic oligopeptides containing part of the amino acid sequences of MexA, MexC, and MexX and detection of OprM and OprJ with monoclonal antibodies specific to OprM or OprJ. Each lane contains 5 μg (MexA and MexC) or 25 μg (MexX) of total membrane protein or 10 μg (OprM) or 1 μg (OprJ) of outer membrane protein. OCR1 (lane 1), N107 (lane 2), KG2259 (lane 3), N108 (lane 4), N126 (lane 5), and N127 (lane 6) were grown in MHB (MexA, MexC, OprM, and OprJ) or MHB containing a subinhibitory concentration of tetracycline (MexX). MHB containing tetracycline at 16 μg/ml (OCR1), 8 μg/ml (N107, KG2259, and N108), or 4 μg/ml (N126 and N127) and approximately 108 CFU of cells per ml was incubated for 2 h at 37°C with shaking.

Similar articles

Cited by

References

    1. Aires J R, Köhler T, Nikaido H, Plésiat P. Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob Agents Chemother. 1999;43:2624–2628. - PMC - PubMed
    1. Fukuoka T, Masuda N, Takenouchi T, Sekine N, Iijima M, Ohya S. Increase in susceptibility of Pseudomonas aeruginosa to carbapenem antibiotics in low-amino-acid media. Antimicrob Agents Chemother. 1991;35:529–532. - PMC - PubMed
    1. Gotoh N, Tsujimoto H, Tsuda M, Okamoto K, Nomura A, Wada T, Nakahashi M, Nishino T. Characterization of the MexC-MexD-OprJ multidrug efflux system in ▵mexA-mexB-oprM mutants of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1998;42:1938–1943. - PMC - PubMed
    1. Gotoh N, Tsujimoto H, Nomura A, Okamoto K, Tsuda M, Nishino T. Functional replacement of OprJ by OprM in the MexCD-OprJ multidrug efflux system of Pseudomonas aeruginosa. FEMS Microbiol Lett. 1998;165:21–27. - PubMed
    1. Iso Y, Irie T, Nishino Y, Motokawa K, Nishitani Y. A novel 1 beta-methylcarbapenem antibiotic, S-4661. Synthesis and structure-activity relationships of 2-(5-substituted pyrrolidin-3-ylthio)-1-beta-methylcarbapenems. J Antibiot (Tokyo) 1996;49:199–209. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources